Optic neuropathy linked to ACAD9 pathogenic variants: a potentially riboflavin-responsive disorder?

[1]  M. Moosajee,et al.  From Transcriptomics to Treatment in Inherited Optic Neuropathies , 2021, Genes.

[2]  M. Soler‐Lopez,et al.  Assembly of The Mitochondrial Complex I Assembly Complex Suggests a Regulatory Role for Deflavination , 2020, Angewandte Chemie.

[3]  P. Bross,et al.  Riboflavin Deficiency—Implications for General Human Health and Inborn Errors of Metabolism , 2020, International journal of molecular sciences.

[4]  M. Lazarou,et al.  Dissecting the Roles of Mitochondrial Complex I Intermediate Assembly (MCIA) Complex Factors in the Biogenesis of Complex I , 2019, bioRxiv.

[5]  Y. Okazaki,et al.  Successful treatment of infantile-onset ACAD9-related cardiomyopathy with a combination of sodium pyruvate, beta-blocker, and coenzyme Q10 , 2019, Journal of pediatric endocrinology & metabolism : JPEM.

[6]  L. Sazanov,et al.  Mammalian Mitochondrial Complex I Structure and Disease-Causing Mutations. , 2018, Trends in cell biology.

[7]  Robert W. Taylor,et al.  Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective? , 2018, Orphanet Journal of Rare Diseases.

[8]  B. Schrank,et al.  Lifetime exercise intolerance with lactic acidosis as key manifestation of novel compound heterozygous ACAD9 mutations causing complex I deficiency , 2017, Neuromuscular Disorders.

[9]  S. Seneca,et al.  Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: Report on nine patients. , 2016, Molecular genetics and metabolism.

[10]  A. Munnich,et al.  High incidence and variable clinical outcome of cardiac hypertrophy due to ACAD9 mutations in childhood , 2015, European Journal of Human Genetics.

[11]  A. Laquérriere,et al.  Lethal Neonatal Progression of Fetal Cardiomegaly Associated to ACAD9 Deficiency. , 2015, JIMD reports.

[12]  Robert W. Taylor,et al.  Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency. , 2015, Human molecular genetics.

[13]  H. te Brinke,et al.  ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies. , 2014, Human molecular genetics.

[14]  C. La Morgia,et al.  The optic nerve: A “mito-window” on mitochondrial neurodegeneration , 2013, Molecular and Cellular Neuroscience.

[15]  M. Tarnopolsky,et al.  Natural disease course and genotype-phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases , 2012, Journal of Inherited Metabolic Disease.

[16]  H. Smeets,et al.  Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene. , 2011, Brain : a journal of neurology.

[17]  Thomas Meitinger,et al.  Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency , 2010, Nature Genetics.

[18]  Rutger O. Vogel,et al.  Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I. , 2010, Cell metabolism.